Climbing dramatically over the past decade. The Food and Drug Administration estimates retail pharmacies stuffed about 174. 1 million prescriptions for extended-release and immediate – opioid pain relievers in 2002. By 2009, this true number had increased to 256.9 million. Related StoriesWomen want different treatment from guys with addiction, says McMaster University-led studyDrug that relieves opioid-induced constipation might help some cancer individuals live longerBraeburn, Camurus announce FDA Fast Monitor designation for CAM2038 to treat opioid addiction In Indiana, counties with higher rates of dentists and pharmacists had even more per-capita opioid prescriptions.Recent and preliminary evaluation of long-term survival data revealed that multiple individuals survived significantly longer than historical controls. The medical data from the CRS-207 trial are now undergoing more intensive review, and detailed outcomes will be released this year later.
A vaccine for multiple sclerosis Apitope Technology Ltd is a biopharmaceutical company that specialises in developing treatments for allergy and autoimmune illnesses. Formed as a spin-out business in 2002, Apitope announced in 2007 a vaccine had been developed by it made to halt multiple sclerosis in its tracks.